Cargando…
RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
INTRODUCTION: Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults. However, treatment strategies have not yet been established for this rare disease. CASE PRESENTATION: A 6-year-old male presented with headache and nausea. CT and MR imagin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715129/ http://dx.doi.org/10.1093/neuonc/noaa222.789 |
_version_ | 1783618882022408192 |
---|---|
author | Nishimoto, Shota Kawanishi, Yu Fujita, Shohei Yawata, Toshio Ueba, Tetsuya |
author_facet | Nishimoto, Shota Kawanishi, Yu Fujita, Shohei Yawata, Toshio Ueba, Tetsuya |
author_sort | Nishimoto, Shota |
collection | PubMed |
description | INTRODUCTION: Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults. However, treatment strategies have not yet been established for this rare disease. CASE PRESENTATION: A 6-year-old male presented with headache and nausea. CT and MR imaging revealed a left frontal mass lesion with slight edema and macrocalcifications. Gross tumor resection was performed. Histological examination found neoplastic cells with astroblastic characteristics, and a striking perivascular array of pseudorosettes. The final diagnosis was high-grade astroblastoma. MR imaging 13 months after surgery suggested local recurrence and enlargement was found 3 months later. Stereotactic radiotherapy (SRT) was performed. MR imaging after SRT showed enhanced cyst formation around the tumor bed, suggesting tumor recurrence. However, (11)C-methionine PET revealed radiation necrosis. The last follow-up MR imaging 15 months after SRT showed no further recurrence. CONCLUSION: Astroblastoma is rare, so no optimal management is known. SRT may be effective to treat recurrent astroblastomas. (11)C-methionine PET/CT is useful for the differentiation from radiation necrosis. |
format | Online Article Text |
id | pubmed-7715129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77151292020-12-09 RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY Nishimoto, Shota Kawanishi, Yu Fujita, Shohei Yawata, Toshio Ueba, Tetsuya Neuro Oncol Radiation Oncology INTRODUCTION: Astroblastoma is a rare, mostly supratentorial glial tumor, occurring predominantly in children and young adults. However, treatment strategies have not yet been established for this rare disease. CASE PRESENTATION: A 6-year-old male presented with headache and nausea. CT and MR imaging revealed a left frontal mass lesion with slight edema and macrocalcifications. Gross tumor resection was performed. Histological examination found neoplastic cells with astroblastic characteristics, and a striking perivascular array of pseudorosettes. The final diagnosis was high-grade astroblastoma. MR imaging 13 months after surgery suggested local recurrence and enlargement was found 3 months later. Stereotactic radiotherapy (SRT) was performed. MR imaging after SRT showed enhanced cyst formation around the tumor bed, suggesting tumor recurrence. However, (11)C-methionine PET revealed radiation necrosis. The last follow-up MR imaging 15 months after SRT showed no further recurrence. CONCLUSION: Astroblastoma is rare, so no optimal management is known. SRT may be effective to treat recurrent astroblastomas. (11)C-methionine PET/CT is useful for the differentiation from radiation necrosis. Oxford University Press 2020-12-04 /pmc/articles/PMC7715129/ http://dx.doi.org/10.1093/neuonc/noaa222.789 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Radiation Oncology Nishimoto, Shota Kawanishi, Yu Fujita, Shohei Yawata, Toshio Ueba, Tetsuya RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY |
title | RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY |
title_full | RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY |
title_fullStr | RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY |
title_full_unstemmed | RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY |
title_short | RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY |
title_sort | ronc-20. recurrent high-grade astroblastoma treated with stereotactic radiotherapy |
topic | Radiation Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715129/ http://dx.doi.org/10.1093/neuonc/noaa222.789 |
work_keys_str_mv | AT nishimotoshota ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy AT kawanishiyu ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy AT fujitashohei ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy AT yawatatoshio ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy AT uebatetsuya ronc20recurrenthighgradeastroblastomatreatedwithstereotacticradiotherapy |